Position in ETON
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,721,229
+$4,521,214 QoQ
Shares Held
158,045
+225.0% QoQ
Ownership
0.553%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#28
of 164 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 45%
Shared 0%
None 55%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Informed Momentum Co LLC holds $23,292,776 across 5 Drug Manufacturers - Specialty & Generic names. ETON ranks #3 (24.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRX |
Amneal Pharmaceuticals, Inc.
|
337,663 | $5,844,946 | |
| 2 | ALKS |
Alkermes plc.
|
110,869 | $5,809,535 | |
| 3 | ETON |
Eton Pharmaceuticals, Inc.
This page
|
158,045 | $5,721,229 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
55,765 | $3,566,171 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
57,297 | $2,350,895 |
All Filings in ETON
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,721,229 | 158,045 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,200,015 | 48,623 | Shares | Sole | 2026-05-13 | |
| 2025-09-30 | $1,149,451 | 52,897 | Shares | Sole | 2025-11-14 | |
| 2025-03-31 | $1,010,272 | 77,833 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,265,653 | 95,019 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $769,656 | 128,276 | Shares | Sole | 2024-11-13 | |
| 2023-09-30 | $1,070,117 | 256,623 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||